Search

Your search keyword '"Bressac-de Paillerets, B."' showing total 341 results

Search Constraints

Start Over You searched for: Author "Bressac-de Paillerets, B." Remove constraint Author: "Bressac-de Paillerets, B."
341 results on '"Bressac-de Paillerets, B."'

Search Results

1. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

2. Recommandations pour le diagnostic de prédisposition génétique au mélanome cutané et pour la prise en charge des personnes à risque

6. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

7. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

8. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

15. The founder mutation MSH2*1906G [right arrow] C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population

18. Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study

19. CTNNA1 : un nouveau gène de prédisposition aux mélanomes familiaux

21. MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort

22. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

23. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families

26. Comprehensive analysis of CDKN2A (p16 (super INK4A)/p14 (super ARF)) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma

27. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

28. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

30. Germline variation at CDKN2A and associations with nevus phenotypes among members of melanoma families

31. Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148

33. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

34. Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families

35. Erratum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma (Nature (2011) 480:94-98 doi:10.1038/nature10539)

36. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma†

37. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

39. Comparative analysis of methods for detecting BRCA1 rearrangements in breastovarian cancer families

40. Polymorphisms in BRCA1 and 17[Beta]-hydroxysteroid dehydrogenase 2 (EDH17B2) genes as modifiers of ovarian cancer risk in carriers of BRCA1 germline mutations

41. A founder mutation in MSH2 in the Ashkenazim

42. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

43. Relationship between genome and epigenome - challenges and requirements for future research

44. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

45. Multiple skin hamartomata: a possible novel clinical presentation of SUFU neoplasia syndrome

48. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

49. Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history

50. Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Catalog

Books, media, physical & digital resources